Her self-experimentation of the company's genetic therapies using heretofore-untested CRISPR-Cas9 gene editing as “Patient Zero” has been controversial within the scientific community, but highly encouraging to transhumanist and life extension advocates.
She owns BioTrove Investments, which in turn owns the news site Longevity Reporter. She is secretary of the American Longevity Alliance and an affiliate member of the Complex Biological Systems Alliance.
- parrishliz on Twitter
- BioViva Interview on Singularity 1 on 1
- 2015 Reddit AMA and LifeMag analysis
- One Year Anniversary of BioViva's Gene Therapy Against Human Aging (written by Liz Parrish)